AVIR – atea pharmaceuticals, inc. - common stock (US:NASDAQ)
Stock Stats
News
Atea Pharmaceuticals (NASDAQ:AVIR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Bullish Atea Pharmaceuticals Insiders Loaded Up On US$5.40m Of Stock [Yahoo! Finance]
Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
Atea Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
Form 4 Atea Pharmaceuticals, For: Jan 31 Filed by: Horga Maria Arantxa
Form 4 Atea Pharmaceuticals, For: Jan 31 Filed by: Vavricka John
Form 4 Atea Pharmaceuticals, For: Jan 31 Filed by: Hammond Janet MJ
Form 4 Atea Pharmaceuticals, For: Jan 31 Filed by: Sommadossi Jean-Pierre
Form 4 Atea Pharmaceuticals, For: Jan 31 Filed by: Corcoran Andrea
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.